Breztri Aerosphere vs Daliresp
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| US Breztri Aerosphere | US Daliresp | |
|---|---|---|
| Generic name | budesonide/glycopyrrolate/formoterol | roflumilast |
| Drug class | Inhaled Corticosteroid + LAMA + LABA | PDE4 Inhibitor (Oral) |
| Treats | COPD | Chronic obstructive pulmonary disease (COPD) |
| Category | Respiratory | Respiratory |
| Manufacturer | AstraZeneca | AstraZeneca |
| Year approved | 2020 | 2011 |
| FDA warning | No boxed warning | Moderate warnings |
| Est. TV ad spend | $120M | — |
| Common side effects | Respiratory infections, Thrush, Cough, Headache | Diarrhea, Weight loss, Nausea, Headache |
Breztri Aerosphere
Frequently asked questions
Is Breztri Aerosphere or Daliresp better?
Neither is universally "better." Breztri Aerosphere (budesonide/glycopyrrolate/formoterol) and Daliresp (roflumilast) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Breztri Aerosphere and Daliresp?
Breztri Aerosphere is a Inhaled Corticosteroid + LAMA + LABA made by AstraZeneca, while Daliresp is a PDE4 Inhibitor (Oral) made by AstraZeneca. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Breztri Aerosphere has the larger estimated TV advertising budget of the two.